'FIX THE SYSTEM': Dr Marty Makary tears into 'great American rip-off'
What this video covers
Appearing on Fox News’ “The Ingraham Angle” in February 2026, then-FDA Commissioner Dr. Marty Makary praised TrumpRx — President Trump’s direct-to-consumer website for lower drug prices — calling it “genius,” while denouncing the American drug-pricing system as a “great American rip-off.” The six-minute segment is a distillation of Makary’s drug-pricing pitch: Americans pay vastly more for the same medicines than patients in other countries, and the administration’s direct-sales model would cut out the middlemen.
The appearance came three months before Makary’s resignation, during a period when he was still publicly aligned with the White House’s health agenda. His framing links high U.S. drug prices to a broken system of intermediaries — insurers, pharmacy benefit managers, and distributors — rather than to FDA regulatory bottlenecks, positioning TrumpRx as a consumer-side fix.
This is Makary in his most populist register: the commissioner as consumer advocate, using the Fox platform to sell the administration’s pricing initiative directly to viewers. The claims about pricing disparities and TrumpRx’s benefits are Makary’s; the site treats them as his arguments, not verified conclusions.
Key points
- Makary calls TrumpRx, the administration’s direct-to-consumer drug-price website, “genius” — a full-throated endorsement from the sitting FDA commissioner.
- He labels the U.S. drug-pricing system a “great American rip-off,” arguing Americans overpay for medicines relative to the rest of the world.
- His pitch targets middlemen — insurers, PBMs, distributors — as the source of inflated prices rather than FDA regulation itself.
- The appearance aired February 2026, three months before his May resignation, during his final stretch of public alignment with the White House.
- The segment is advocacy, not policy detail: a six-minute cable hit selling the pricing initiative to a friendly audience.